Azacitidine and Mitoxantrone hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azacitidine (azacitidine) and Mitoxantrone hydrochloride (mitoxantrone hydrochloride). Common drug interactions include device related infection among females and arrhythmia among males.

The phase IV clinical study analyzes what interactions people have when they take Azacitidine and Mitoxantrone hydrochloride. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Azacitidine?

Azacitidine has active ingredients of azacitidine. eHealthMe is studying from 17,184 Azacitidine users. Check the latest studies of Azacitidine.

What is Mitoxantrone hydrochloride?

Mitoxantrone hydrochloride has active ingredients of mitoxantrone hydrochloride. eHealthMe is studying from 1,060 Mitoxantrone hydrochloride users. Check the latest studies of Mitoxantrone hydrochloride.

On Jul, 14, 2026

13 people who take Azacitidine and Mitoxantrone hydrochloride together, and have interactions are studied.

Azacitidine and Mitoxantrone hydrochloride drug interactions.

What are the common drug interactions of Azacitidine and Mitoxantrone Hydrochloride, by gender? *:

female:

Device related infection
Disease progression
Drug ineffective
Graft versus host disease in lung (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the lung)
Stenotrophomonas infection
Pneumonia
Bone neoplasm (tumour of bone)
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)

male:

Arrhythmia (irregular heartbeat)
Fungal infection
Pericarditis infective (inflammation of the pericardium-infective)
Sepsis (a severe blood infection that can lead to organ failure and death)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Cardiac arrest
Leukaemia (blood or bone marrow cancer)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

What are the common drug interactions of Azacitidine and Mitoxantrone Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Device related infection
Disease progression
Drug ineffective
Graft versus host disease in lung (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the lung)
Stenotrophomonas infection
Bone neoplasm (tumour of bone)

40-49:

n/a

50-59:

Arrhythmia (irregular heartbeat)
Pericarditis infective (inflammation of the pericardium-infective)

60+:

Fungal infection
Sepsis (a severe blood infection that can lead to organ failure and death)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Cardiac arrest
Leukaemia (blood or bone marrow cancer)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pneumonia

What are the existing conditions these people have? *

Obliterative Bronchiolitis (bronchiolar inflammation): 5 people, 38.46%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 5 people, 38.46%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 30.77%
Venous Occlusion (the blocking of venous return): 2 people, 15.38%
Venoocclusive Liver Disease (small veins in the liver are obstructed): 2 people, 15.38%
Fungal Infection: 2 people, 15.38%
Bone Marrow Conditioning Regimen: 2 people, 15.38%
Pneumonia Fungal: 1 person, 7.69%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 7.69%
Multiple Myeloma (cancer of the plasma cells): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Azacitidine and Mitoxantrone hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously